The frequency of antibodies against cyclic citrullinated peptides and rheumatoid factor in healthy population: A field study of rheumatoid arthritis from northern turkey

Rheumatology International

Volumn 33, Issue 4, 2013, Pages 939-942

  Tasliyurt, Turker ^a   Kisacik, Bunyamin ^b,c   Kaya, Suheyla Uzun ^a   Yildirim, Beytullah ^d   Pehlivan, Yavuz ^b   Kutluturk, Faruk ^a   Ozyurt, Huseyin ^a   Sahin, Semsettin ^a   Onat, Ahmet Mesut ^b  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b Gaziantep Faculty of Medicine   (Turkey)

^c GAZIANTEP UNIVERSITY   (Turkey)

^d Faculty of Medicine   (Turkey)

Author keywords

Anti cyclic citrullinated peptid; Field study; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; AUTOANTIBODY; BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RURAL AREA; SAMPLING; TURKEY (REPUBLIC); URBAN AREA; YOUNG ADULT; ADOLESCENT; IMMUNOLOGY;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; TURKEY;

EID: 84886624353     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2458-5     Document Type: Article

References (23)

1. Alamanos Y, Drosos AA (2005) Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 4: 130-136
2. Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358: 903-911
3. Klareskog L, Catrina AI, Paget S (2009) Rheumatoid arthritis. Lancet 373(659):672
4. Schellekens GA, Visser H, de Jong BA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43: 155-163
5. Westwood MR, Nelson PN, Hay FC (2006) Rheumatoid factors: what's new? Rheumatology 45: 379-385
6. Lee AN, Beck CE, Hall M (2008) Rheumatoid factor and anti- CCP antibodies in rheumatoid arthritis: a review. Clin Lab Sci 21: 15-18
7. Aletaha D, Neogi T, Silman AJ et al (2010) Rheumatoid arthritis classification criteria. Arthritis Rheum 62: 2569-2581
8. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324
9. Akar S, Birlik M, Guler O et al (2004) The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey. Clin Exp Rheumatol 22: 416-420
10. Kacar C, Gilgil E, Tuncer T et al (2005) Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 24: 212-214
11. Capkin E, Cakirbay H, Karkucak M et al (2010) Prevalence of rheumatoid arthritis in the eastern Black Sea region of Turkey. Int J Rheum Dis 13(4): 380-384
12. Cakir N, Pamuk ÖN, Derviş E et al (2012) The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int 32(4): 895-908
13. Van Venrooij WJ, Pruijn GJ (2000) Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2(4): 249-251
14. Kakumanu P, Yamagata H, Sobel ES et al (2008) Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide. Arthritis Rheum 58(6): 1576-1581
15. Kakumanu P, Sobel ES, Narain S et al (2009) Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis. J Rheumatol 36(12): 2682-2690
16. Gottenberg JE, Mignot S, Nicaise-Rolland P et al (2005) Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome. Ann Rheum Dis 64(1): 114-117
17. Ingegnoli F, Galbiati V, Zeni S et al (2007) Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. Clin Rheumatol 26(4): 510-514
18. Takasaki Y, Yamanaka K, Takasaki C et al (2004) Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease. Mod Rheumatol 14(5): 367-375
19. Li T, Bao J, Yin J et al (2011) The specificity of anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis from a large cohort study in the Chinese. Zhonghua Nei Ke Za Zhi. 50(2): 99-101
20. Goeldner I, Skare TL, de Messias Reason IT et al (2010) Anticyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil. Rheumatology (Oxford) 49(8): 1590-1593
21. Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65(7): 845-851
22. Lipsky PE (2005) Rheumatoid arthritis. In: Braunwald E (ed) Harrison's 16th edition Principles of Internal Medicine. Mc Graw Hill, New York, pp 1968-1976
23. Klareskog L, Stolt P, Lundberg K et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA- DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54: 38-46